m+Medelevator.RU
← Поиск публикаций
Biomaterials · 2026

Microenvironment-responsive dual-network hydrogel with stage-adapted release promotes diabetic bone regeneration.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Lu Xiaoheng, Sheng Qifeng, Wang Qihan, Lu Chengyao, Zhang Ziyu, Xu Hao, Deng Yongkang, Lu Wei, Geng Dechun, Xu Yaozeng

Аннотация

Diabetic bone regeneration is severely hindered by hyperglycemia-induced inflammation and microangiopathy. In this case, conventional drug strategies show limited efficacy. Inspired by the natural polyphenol structure, this study engineered a dual-network self-assembled hydrogel with glucose responsiveness and stage-adapted release characteristics. Punicalagin (PUN), a natural floral tannin with anti-inflammatory and antioxidant properties, contains abundant catechol groups. Based on the primary network formed by dynamic phenylboronic ester bonds, the hydrogel responds sensitively to the local hyperglycemia microenvironment. The stable secondary cross-linking formed by metal-polyphenol coordination endows the hydrogel with excellent mechanical properties. Rapidly released PUN reduces excessive inflammation by inhibiting pro-inflammatory cytokines and promoting macrophage polarization toward the regenerative M2 phenotype. The sustained release of cobalt ions (Co2+) promotes endothelial cell viability. In vivo results show that the synergistic effect of the two bioactive components regulates the osteoimmune microenvironment, accelerates the reconstruction of the functional vascular network, and ultimately facilitates bone regeneration. In this process, Co-Gel-PUN (CGP) hydrogel regulated the osteogenic microenvironment by inhibiting the JAK2/STAT1 pathway. The proposed "immune-angiogenesis" dual-regulatory strategy provides an effective therapeutic paradigm for diabetic bone regeneration.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты